An activating KRAS mutation in imatinib-resistant chronic myeloid leukemia. Article uri icon

Overview

publication date

  • May 29, 2008

Research

keywords

  • Antineoplastic Agents
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Piperazines
  • Proto-Oncogene Proteins
  • Pyrimidines
  • ras Proteins

Identity

Scopus Document Identifier

  • 57849142069

Digital Object Identifier (DOI)

  • 10.1038/leu.2008.124

PubMed ID

  • 18509354

Additional Document Info

volume

  • 22

issue

  • 12